Cerebrovascular lesions induce transient -amyloid deposition
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Previous clinical studies have documented a close relationship between cerebrovascular disease and risk of Alzheimer's disease. We examined possible mechanistic interactions through use of experimental stroke models in a transgenic mouse model of β-amyloid deposition (APPswe/PS1dE9). Following middle cerebral artery occlusion, we observed a rapid increase in amyloid plaque burden in the region surrounding the infarction. In human tissue samples, however, we were unable to detect a localized increase in amyloid burden adjacent to cerebral infarcts. To resolve this discrepancy, we generated cerebral microstrokes in amyloid precursor protein mouse models with the photosensitive dye Rose bengal, and monitored plaque formation in real time using multiphoton microscopy. We observed a striking increase in the number of new plaques and amyloid angiopathy in the area immediately surrounding the infarcted area; however, the effect was transient, potentially resolving the discord between mouse and human tissue. We did not detect changes in candidate proteins related to β-amyloid generation or degradation such as β-amyloid-converting enzyme, amyloid precursor protein, presenilin 1, neprylisin or insulin-degrading enzyme. Together, these results demonstrate that strokes can trigger accelerated amyloid deposition, most likely through interference with amyloid clearance pathways. Additionally, this study indicates that focal ischaemia provides an experimental paradigm in which to study the mechanisms of plaque seeding and growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cerebral ischemia promotes amyloid plaque formation (Garcia-Alloza et al., 2011; Kitaguchi et al., 2009; Okamoto et al., 2012)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Garcia-Alloza et al., 2011
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 2×
“, 2004), plasma homocysteine (Seshadri et al., 2002), tobacco use (Ott et al.”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 2×
“The increase in the amyloid burden was the result of the generation of new plaques, and not the growth of existing plaques in concordance with previous observations (Garcia-Alloza et al., 2006; Meyer-Luehmann et al., 2008).”
ResultSelf-citationMetabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Launer, L. J. (1995) · JAMA · doi:10.1001/jama.1995.03530230032026 · Cited by 908
American Journal of Human Genetics
(2005) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess7082.pub2 · Cited by 874
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 746
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · cited 2×
“The increase in the amyloid burden was the result of the generation of new plaques, and not the growth of existing plaques in concordance with previous observations (Garcia-Alloza et al., 2006; Meyer-Luehmann et al., 2008).”
ResultSelf-citationHyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683
Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00133.x · Cited by 681
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664 · cited 2×
“…to an individual’s risk of dementia and might thus contribute to the observed associations between vascular risk factors and dementia in humans (Elias et al., 1993; Breteler, 1994, 2000; Launer et al., 1995; Kalaria, 2000; Roher et al., 2003; Luchsinger and Mayeux, 2004; Honig et al., 2005).”
BackgroundUntreated Blood Pressure Level Is Inversely Related to Cognitive Functioning: The Framingham Study
Elias, M. F., Wolf, P. A., D'Agostino, R. B., Cobb, J., & White, L. R. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116868 · Cited by 652
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645
Kuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614 · cited 1×
“The yellow fluorescent protein was part of a larger cassette that was prepared and injected as previously described (Kuchibhotla et al., 2008).”
MethodSelf-citationHypertension and cerebral white matter lesions in a prospective cohort study
de Leeuw, F. ‐., de Groot, J. C., Oudkerk, M., Witteman, J. C. M., Hofman, A., van Gijn, J., & Breteler, M. M. B. (2002) · Brain · doi:10.1093/brain/awf077 · Cited by 614
Leys, D., Hénon, H., Mackowiak-Cordoliani, M.-A., & Pasquier, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70221-0 · Cited by 609
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 2×
“In certain hypoxia models, it has been shown that hypoxia facilitates APP processing by an upregulation of BACE1 gene transcription (Sun et al., 2006) and that it may also facilitate b- and -cleavage (Li et al., 2009).”
BackgroundRelation of diabetes to mild cognitive impairment
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.570 · Cited by 592
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study
Breteler, M. M. B., Claus, J. J., Grobbee, D. E., & Hofman, A. (1994) · BMJ · doi:10.1136/bmj.308.6944.1604 · Cited by 541
Ott, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535
The role of cerebral ischemia in Alzheimer’s disease
Kalaria, R. N. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00125-1 · Cited by 521
Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P., Schenk, D., & Hyman, B. T. (2001) · Nature Medicine · doi:10.1038/85525 · Cited by 449
Self-citationChartier-Hariln, M.-C., Parfitt, M., Legrain, S., Pérez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vldal, O., Roques, P., Gourlet, V., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.569 · Cited by 438
Hypertension and the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1734 · Cited by 360
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · cited 2×
“Although we cannot exclude that alternative methods could detect differences in BACE, as previously shown in ischaemic Sprague-Dawley rats (Tesco et al., 2007), the use of standard immunohistochemistry approaches to detect differences between the ischaemic and non-ischaemic areas in animals has…”
ResultContribution of Vascular Risk Factors to the Progression in Alzheimer Disease
Helzner, E. P., Luchsinger, J. A., Scarmeas, N., Cosentino, S., Brickman, A. M., Glymour, M. M., & Stern, Y. (2009) · Archives of Neurology · doi:10.1001/archneur.66.3.343 · Cited by 332
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4f6 · Cited by 328
A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system
Bateman, R. J., Siemers, E. R., Mawuenyega, K. G., Wen, G., Browning, K. R., Sigurdson, W. C., Yarasheski, K. E., Friedrich, S. W., DeMattos, R. B., May, P. C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21623 · Cited by 322 · cited 1×
“…suggested for inhibiting the b-amyloid pathway (McLaurin et al., 2000; Bacskai et al., 2001; Townsend et al., 2006; Prada et al., 2007; Rajendran et al., 2008; Bateman et al., 2009; Elvang et al., 2009; Garcia-Alloza et al., 2009b) none has yet been shown to block progression of the human diseases.”
BackgroundAtherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center
Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease
Roher, A. E., Esh, C., Kokjohn, T. A., Kalback, W., Luehrs, D. C., Seward, J. D., Sue, L. I., & Beach, T. G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000095973.42032.44 · Cited by 280
The Metabolic Syndrome and Alzheimer Disease
Razay, G., Vreugdenhil, A., & Wilcock, G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.93 · Cited by 272
McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906994199 · Cited by 266
Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting
Rajendran, L., Schneider, A., Schlechtingen, G., Weidlich, S., Ries, J., Braxmeier, T., Schwille, P., Schulz, J. B., Schroeder, C., Simons, M., et al. (2008) · Science · doi:10.1126/science.1156609 · Cited by 262
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
Pappolla, M. A., Bryant-Thomas, T. K., Herbert, D., Pacheco, J., Fabra Garcia, M., Manjon, M., Girones, X., Henry, T. L., Matsubara, E., Zambon, D., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000070182.02537.84 · Cited by 247
Cardiovascular risk factors and Alzheimer’s disease
Luchsinger, J. A., & Mayeux, R. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0056-z · Cited by 238
Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., & Le, W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.011 · Cited by 221
Zhang, F., Eckman, C., Younkin, S., Hsiao, K. K., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07655.1997 · Cited by 205 · cited 5×
“…with previous studies where increased stroke volumes were observed in transgenic mice with Alzheimer’s disease, when compared with wild-type mice (Zhang et al., 1997; Koistinaho et al., 2002), supporting the possibility of increased susceptibility to ischaemia as a result of neurotoxic effects…”
BackgroundResultInfluentialEckman, E. A., Adams, S. K., Troendle, F. J., Stodola, B. A., Kahn, M. A., Fauq, A. H., Xiao, H. D., Bernstein, K. E., & Eckman, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605827200 · Cited by 196 · cited 2×
“Moreover, it seems that neprilysin activity is independent of other b-amyloid degrading enzymes, such as endothelin-converting enzymes (Eckman et al., 2006).”
BackgroundZhang, S., & Murphy, T. H. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050119 · Cited by 193 · cited 5×
“Red blood cell velocity was assessed using repeated line scans of the same area at 860 nm ( 6 zoom) through the horizontal part of the selected region of interest as previously described (Zhang and Murphy, 2007).”
MethodInfluentialIncreased β-secretase activity and expression in rats following transient cerebral ischemia
Wen, Y., Onyewuchi, O., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2003.09.086 · Cited by 188
van Groen, T., Puurunen, K., Mäki, H.-M., Sivenius, J., & Jolkkonen, J. (2005) · Stroke · doi:10.1161/01.str.0000169933.88903.cf · Cited by 183
McLellan, M. E., Kajdasz, S. T., Hyman, B. T., & Bacskai, B. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02212.2003 · Cited by 174
Self-citationOrally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers
Townsend, M., Cleary, J. P., Mehta, T., Hofmeister, J., Lesne, S., O'Hare, E., Walsh, D. M., & Selkoe, D. J. (2006) · Annals of Neurology · doi:10.1002/ana.21051 · Cited by 167
Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan.
Masuda, J., Tanaka, K., Ueda, K., & Omae, T. (1988) · Stroke · doi:10.1161/01.str.19.2.205 · Cited by 164
The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological Studies
Hyman, B. T. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00066-3 · Cited by 162
Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinänen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032670899 · Cited by 159
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
Bickeböller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Pérez‐Tur, J., Michon, A., et al. (1997) · Europe PMC (PubMed Central) · Cited by 153
Shin, H. K., Nishimura, M., Jones, P. B., Ay, H., Boas, D. A., Moskowitz, M. A., & Ayata, C. (2008) · Stroke · doi:10.1161/strokeaha.107.499483 · Cited by 150
Self-citationPoststroke Dementia: Influence of Hippocampal Atrophy
Cordoliani-Mackowiak, M.-A., Hénon, H., Pruvo, J.-P., Pasquier, F., & Leys, D. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.585 · Cited by 126
AD brain pathology: Vascular origins?
Launer, L. J., Petrovitch, H., Ross, G. W., Markesbery, W., & White, L. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.008 · Cited by 117
Rastas, S., Verkkoniemi, A., Polvikoski, T., Juva, K., Niinistö, L., Mattila, K., Länsimies, E., Pirttilä, T., & Sulkava, R. (2007) · Stroke · doi:10.1161/strokeaha.106.477299 · Cited by 100
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
Robbins, E. M., Betensky, R. A., Domnitz, S. B., Purcell, S. M., Garcia-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3854-05.2006 · Cited by 84
Self-citationGarcia-Alloza, M., Subramanian, M., Thyssen, D., Borrelli, L. A., Fauq, A., Das, P., Golde, T. E., Hyman, B. T., & Bacskai, B. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-19 · Cited by 72
Self-citationStone, J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.007 · Cited by 67
Hiltunen, M., Mäkinen, P., Peräniemi, S., Sivenius, J., van Groen, T., Soininen, H., & Jolkkonen, J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.009 · Cited by 65
Mäkinen, S., van Groen, T., Clarke, J., Thornell, A., Corbett, D., Hiltunen, M., Soininen, H., & Jolkkonen, J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600529 · Cited by 64
Garcia‐Alloza, M., Prada, C., Lattarulo, C., Fine, S., Borrelli, L. A., Betensky, R., Greenberg, S. M., Frosch, M. P., & Bacskai, B. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06096.x · Cited by 64
Self-citationPrada, C. M., Garcia-Alloza, M., Betensky, R. A., Zhang-Nunes, S. X., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5426-06.2007 · Cited by 56
Self-citationAntioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
García-Alloza, M., Borrelli, L. A., Hyman, B. T., & Bacskai, B. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.006 · Cited by 48
Self-citationThalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction
Nandhagopal, R., Vengamma, B., Krishnamoorthy, S. G., Rajasekhar, D., & Subramanyam, G. (2005) · Neurology · doi:10.1212/01.wnl.0000171339.96234.b5 · Cited by 32
Risk of Alzheimer's disease incidence attributable to vascular disease in the population
Dodge, H. H., Chang, C. H., Kamboh, M. I., & Ganguli, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.004 · Cited by 29
Differential effects of γ‐secretase and BACE1 inhibition on brain Aβ levels in vitro and in vivo
Elvang, A. B., Volbracht, C., Pedersen, L. Ø., Jensen, K. G., Karlsson, J.-J., Larsen, S. A., Mørk, A., Stensbøl, T. B., & Bastlund, J. F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06215.x · Cited by 27
Yow, H. Y., & Weller, R. O. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.39286_4.x · Cited by 17
The Medical Editor.—A Democratic Despot
Soffer, A. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.2.149 · Cited by 12
Research works printed but not linked: 2
- 2007, 54, 721
- 2002, Neuropathology and applied neurobiology, 28, 149
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Self-citationRegulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 915
Metadata
- Authors
- Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11-26
- Volume
- 134
- Issue
- 12
- Pages
- 3697-3707
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3235567
- OpenAlex
- W2121469208
- Cited by
- 187
- References
- 69
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 11 · 2023: 8 · 2022: 7 · 2021: 21 · 2020: 13 · 2019: 13 · 2018: 14 · 2017: 17 · 2016: 9 · 2015: 15 · 2014: 17 · 2013: 9 · 2012: 10
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Aging (AG005134, R01AG021084, AG021084, P50AG005134)
- National Institute of Biomedical Imaging and Bioengineering (EB-00768, R01EB000768)
- National Center for Research Resources (S10RR025645)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- cerebrovascular disease, amyloid-beta deposition, Alzheimer's disease, cerebral infarction, amyloid plaques, amyloid angiopathy, middle cerebral artery occlusion, amyloid clearance, APP/PS1 mice, rose bengal, multiphoton microscopy
- MeSH terms
- Alzheimer Disease, Animals, Brain, Brain Ischemia, Humans, Insulysin, Neurons, Neprilysin, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Stroke, Mice, Presenilin-1, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.